Investing.com - Financial Markets Worldwide

American Airlines Group (A1G)

Frankfurt
Symbol
Exchange
Currency
AALNASDAQUSD
0HE6LondonUSD
AALBIVAMXN
AALMexicoMXN
1AALMilanEUR
A1GFrankfurtEUR
A1GTradeGateEUR
AALmBuenos AiresARS
AALL34B3BRL
AALDViennaEUR
AAL_KZKASEUSD
AALLimaUSD
Currency in EUR
10.17
-0.23(-2.21%)
Closed

A1G Comments

pro badge
I just got rid of the shares. I don't see things well, the indices will fall soon. This can't go up. Even irobot, which is ready to call, gained +6%.
pro badge
I'm sorry to say it. It doesn't want to go up...and that means it will go down today.
second corona is coming
AAL is getting beat up by news but will have a big rebound when it reaches its turning point
glad I sold a few days ago
Hii
American Airlines flight collides with helicopter in Washington DC
PSA airlines (regional partner) flight collided with helicopter. doing business under American airlines
Hii
All American Airlines flights grounded due to 'technical issue'
....for 45 mins
Every time it goes up it suffers bearish attacks, it's ridiculous while there are stocks at bubble level that don't stop going up
AAL seems to have corrected the direction of the company so they can meet the forecasted quarterly estimates. However, the gapping hole in their cashflow shows how tightly the money is. Their debt and liabilities have much to be desired. I see AAL as a short term investment to grab for value with holiday traveling. But long term, I'd look elsewhere.
American Airlines flight makes emergency landing at LAX
now , 10 is near
This is real Big shit
Make america great again
stay cautious
 ProKidney (NASDAQ: PROK) sees a significant surge from $2 to nearly $14 potential.  The company is advancing its chronic kidney disease (CKD) treatment with two Phase 3 trials back on track.  Strong Financials: ProKidney holds $431.5 million in cash, close to its $500 million market cap.  Upgraded Forecasts: BofA Securities has increased its sales predictions for ProKidney's lead therapy, REACT, with peak sales expected to reach $1.8 billion.  Billionaire Pablo Legorreta, founder of Royalty Pharma, recently invested €57M in the company.  PROK could rise back to $14 or even higher by the end of the year.
Even in the worst nightmares of pandemic period AAL hit as low as 10.56 usd. Today its results are much and much better and now 9.80 usd. If anyone who has sane should understand that when the fog diminishes the price should hit 14 and above.
imo shorts & summer
This time is not covid , it is war , and I believe it is going to get worse
Americans should fly with their own wings now
worst company ever! hope they go bankrupt
It was a good news from AAL…13.75 soon
How seen
hold and buying
buying?
Told ya,it cannot fall forever,where are the sceptics from ZACK?Good luck :)
???
just let this fall to 1 cent then we can own this company
Robert Isom CEO on sqwak box right now smiling from ear to ear. Run away! Crash coming
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.